EYEBIOTECH.COM: Keyword Density Checker

Total words: 2871 | 2-word phrases: 746 | 3-word phrases: 848 | 4-word phrases: 876

PAGE INFO

Title	Try to keep the title under 60 characters (13 characters) Home \| EyeBio
Description	Try to keep the meta description between 50 - 160 characters (80 characters) Developing a new generation of therapies to protect, restore, and improve vision
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (80 characters) Developing a new generation of therapies to protect, restore, and improve vision

#	Keyword	Frequency	Density
1	anthony p adamis	5	0.59%
2	p adamis md	4	0.47%
3	senior vice president	4	0.47%
4	sv health investors	3	0.35%
5	new generation of	3	0.35%
6	acquisition of eyebio	3	0.35%
7	2023 eyebio announces	3	0.35%
8	vice president of	3	0.35%
9	read anthony p	2	0.24%
10	ng ph d	2	0.24%
11	merck completes acquisition	2	0.24%
12	completes acquisition of	2	0.24%
13	president of clinical	2	0.24%
14	read more february	2	0.24%
15	eric ng ph	2	0.24%
16	paul stephens phd	2	0.24%
17	d senior vice	2	0.24%
18	eyebio read more	2	0.24%
19	and improve vision	2	0.24%
20	mike ross phd	2	0.24%
21	board of directors	2	0.24%
22	with eye diseases	2	0.24%
23	therapies for eye	2	0.24%
24	to develop a	2	0.24%
25	partner sv health	2	0.24%
26	an experienced team	2	0.24%
27	learn more about	2	0.24%
28	related macular degeneration	2	0.24%
29	srinivas akkaraju md	2	0.24%
30	14 2023 eyebio	2	0.24%

#	Keyword	Frequency	Density
1	anthony p adamis md	4	0.46%
2	senior vice president of	3	0.34%
3	d senior vice president	2	0.23%
4	14 2023 eyebio announces	2	0.23%
5	partner sv health investors	2	0.23%
6	new generation of therapies	2	0.23%
7	a new generation of	2	0.23%
8	anthony p adamis mdsbio	2	0.23%
9	read anthony p adamis	2	0.23%
10	eric ng ph d	2	0.23%
11	merck completes acquisition of	2	0.23%
12	completes acquisition of eyebio	2	0.23%
13	general partner samsara biocapital	1	0.11%
14	partner samsara biocapital read	1	0.11%
15	srinivas akkaraju md phdsbio	1	0.11%
16	skip to primary navigation	1	0.11%
17	akkaraju md phdsbio bernard	1	0.11%
18	md phdsbio bernard davitian	1	0.11%
19	and managing general partner	1	0.11%
20	phdsbio bernard davitian partner	1	0.11%
21	bernard davitian partner omega	1	0.11%
22	davitian partner omega funds	1	0.11%
23	partner omega funds read	1	0.11%
24	bernard davitiansbio evelyn harrison	1	0.11%
25	davitiansbio evelyn harrison svp	1	0.11%
26	evelyn harrison svp chief	1	0.11%
27	harrison svp chief clinical	1	0.11%
28	managing general partner samsara	1	0.11%
29	adamis mdsbio srinivas akkaraju	1	0.11%
30	founder and managing general	1	0.11%
31	bingham dbesbio anthony p	1	0.11%
32	bingham dbe managing partner	1	0.11%
33	dbe managing partner sv	1	0.11%
34	managing partner sv health	1	0.11%
35	sv health investors eyebio	1	0.11%
36	health investors eyebio board	1	0.11%
37	investors eyebio board chair	1	0.11%
38	read kate bingham dbesbio	1	0.11%
39	kate bingham dbesbio anthony	1	0.11%
40	dbesbio anthony p adamis	1	0.11%

#	URL	Whois	Check
1	https://www.linkedin.com/company/eyebio/about/	Whois	linkedin.com
2	https://eyebiotech.wpengine.com	Whois	wpengine.com